Description
| Product Name | CAT.No | Size |
| CEA | CEAC0040 | 40T |
Product Description
The Biorex Diagnostics CEA Rapid Test Device is a rapid, instrument-free immunochromatographic assay designed for the qualitative detection of carcinoembryonic antigen in human whole blood, serum, or plasma. This test provides fast and reliable screening to support monitoring of tumor markers in patients with malignancies, aiding in early detection, treatment evaluation, and recurrence surveillance. Its ease of use and rapid results make it ideal for clinical laboratories, hospitals, oncology clinics, and point-of-care settings.
The device offers a convenient solution for healthcare professionals who require timely information for patient management. The one-step procedure allows for clear visual interpretation of results within minutes, without the need for specialised instruments or extensive training. Its high sensitivity and specificity ensure that elevated levels of this tumor marker are accurately identified, enabling clinicians to make informed decisions and tailor patient care.
Key Features
- Rapid immunochromatographic detection – clear qualitative results within minutes
- High sensitivity and specificity – reliable identification of abnormal marker levels
- Versatile sample compatibility – works with whole blood, serum, or plasma
- Instrument-free – suitable for point-of-care, clinic, or laboratory use
- Ready-to-use format – minimal preparation, straightforward interpretation, reduced errors
Benefits
Use of the CEA Rapid Test Device supports clinical decision-making for cancer management, including early detection, monitoring of therapeutic response, and identification of disease recurrence. Its rapid workflow and ease of use improve laboratory efficiency, allowing timely screening and follow-up for patients at risk.
This device is particularly valuable in oncology monitoring, aiding healthcare providers in evaluating disease progression and treatment efficacy. Its consistent and reliable performance supports patient care while contributing to improved operational efficiency in medical facilities. By combining speed, accuracy, and simplicity, the test offers a dependable solution for tumor marker assessment and enhanced patient management in diverse clinical environments.
Contact Us for more information.